[Funding alert] Scotland-based Carcinotech Secures £4.2Million in Funding

Read also - Limburg-based Foodtech Company Verdify Raises €2.4Million in Funding

The money will be used by the business to increase operations and R&D. headed by CEO and Founder Ishani Malhotra.

With the help of Carcinotech's Carcino3D product, which uses cells from patient biopsies and blood samples to create 3D printed microtumours that accurately mimic the tumor microenvironment, more ethical drug screening can be completed more quickly and more potent cancer treatments can be brought to market.

Read also -  Netherlands-based Tidal Control Secures €500K in a Pre-Seed Round Funding

Ishani Malhotra said: “Our vision is to be at the forefront of cancer drug testing and provide personalised medicine testing to every individual suffering from cancer to improve their treatment and chance of survival. Working with global partners, leading pharma companies, surgeons, pathologists, and clinicians, Carcinotech aims to significantly accelerate oncology drug development.”

About Carcinotech

This MedTech startup, Carcinotech, specializes in 3D printed micro-tumours made from cancer stem cells, primary cells, immune cells, and patient-derived biopsies. Carcinotech's sophisticated models offer a platform for pre-clinical and customized medicine testing, as well as quick, moral, and accurate drug screening.

Read also - Amsterdam-based Send AI Raises €2.2Million in a Pre-Seed Round Funding